Literature DB >> 21838793

Diuretics and epilepsy: will the past and present meet?

Edward H Maa1, Kristopher T Kahle, Brian P Walcott, Mark C Spitz, Kevin J Staley.   

Abstract

Clinical studies from over half a century ago suggested efficacy of a variety of diuretics in focal and generalized epilepsies as well as in status epilepticus, but these findings have not been translated into modern epilepsy training or practice. Recent advances in our understanding of neuronal maturation and the pathophysiology of neonatal seizures provide fresh insight into the mechanisms by which diuretics might reduce susceptibility to seizures. In vitro and in vivo rodent studies and human epilepsy surgical cases have shown that specific diuretic agents targeting the cation-chloride cotransporters decrease neuronal synchrony and neuronal hyperexcitability. These agents are thought to convey their antiepileptic activity by either expanding the extracellular space or promoting a cellular chloride transport balance that reflects a more developmentally "mature," less excitable state. It may be time to reexamine whether diuretics could serve as adjunctive therapies in the treatment of refractory epilepsies. Wiley Periodicals, Inc.
© 2011 International League Against Epilepsy.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21838793     DOI: 10.1111/j.1528-1167.2011.03203.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  12 in total

1.  Dephosphorylation proves detrimental to GABAergic inhibition.

Authors:  Nicholas P Poolos
Journal:  Epilepsy Curr       Date:  2012-01       Impact factor: 7.500

Review 2.  Novel treatment targets for cerebral edema.

Authors:  Brian P Walcott; Kristopher T Kahle; J Marc Simard
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

Review 3.  Depolarizing GABA and developmental epilepsies.

Authors:  Roustem Khazipov; Guzel Valeeva; Ilgam Khalilov
Journal:  CNS Neurosci Ther       Date:  2014-12-01       Impact factor: 5.243

4.  Furosemide depresses the presynaptic fiber volley and modifies frequency-dependent axonal excitability in rat hippocampus.

Authors:  Mogens Andreasen; Steen Nedergaard
Journal:  J Neurophysiol       Date:  2017-01-18       Impact factor: 2.714

5.  Jointly reduced inhibition and excitation underlies circuit-wide changes in cortical processing in Rett syndrome.

Authors:  Abhishek Banerjee; Rajeev V Rikhye; Vincent Breton-Provencher; Xin Tang; Chenchen Li; Keji Li; Caroline A Runyan; Zhanyan Fu; Rudolf Jaenisch; Mriganka Sur
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-01       Impact factor: 11.205

6.  Reversing excitatory GABAAR signaling restores synaptic plasticity and memory in a mouse model of Down syndrome.

Authors:  Gabriele Deidda; Martina Parrini; Shovan Naskar; Ignacio F Bozarth; Andrea Contestabile; Laura Cancedda
Journal:  Nat Med       Date:  2015-03-16       Impact factor: 53.440

7.  Limitations of Current GABA Agonists in Neonatal Seizures: Toward GABA Modulation Via the Targeting of Neuronal Cl(-) Transport.

Authors:  Arjun Khanna; Brian Patrick Walcott; Kristopher T Kahle
Journal:  Front Neurol       Date:  2013-06-25       Impact factor: 4.003

Review 8.  Modulation of GABAergic transmission in development and neurodevelopmental disorders: investigating physiology and pathology to gain therapeutic perspectives.

Authors:  Gabriele Deidda; Ignacio F Bozarth; Laura Cancedda
Journal:  Front Cell Neurosci       Date:  2014-05-22       Impact factor: 5.505

9.  Developmental excitatory-to-inhibitory GABA-polarity switch is disrupted in 22q11.2 deletion syndrome: a potential target for clinical therapeutics.

Authors:  Hayder Amin; Federica Marinaro; Davide De Pietri Tonelli; Luca Berdondini
Journal:  Sci Rep       Date:  2017-11-16       Impact factor: 4.379

10.  Early depolarizing GABA controls critical-period plasticity in the rat visual cortex.

Authors:  Gabriele Deidda; Manuela Allegra; Chiara Cerri; Shovan Naskar; Guillaume Bony; Giulia Zunino; Yuri Bozzi; Matteo Caleo; Laura Cancedda
Journal:  Nat Neurosci       Date:  2014-12-08       Impact factor: 24.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.